v3.26.1
Loss per share of common stock
6 Months Ended
Jun. 30, 2026
Loss per share of common stock  
Loss per share of common stock

10.Loss per share of common stock

The following table sets forth the computation of basic and diluted loss per share of common stock (in thousands, except share and per share amounts):

Three Months Ended June 30,

Six Months Ended June 30,

2026

2025

2026

2025

Numerator:

Net loss

$

(5,316)

$

(3,995)

$

(9,139)

$

(7,666)

Denominator:

Weighted average shares of common stock, basic

5,931,875

1,389,753

5,398,683

1,162,692

Effect of dilutive securities

Weighted average shares of common stock, diluted

5,931,875

1,389,753

5,398,683

1,162,692

Loss per share of common stock, basic and diluted

$

(0.90)

$

(2.87)

$

(1.69)

$

(6.59)

For each of the periods presented in the above table, our basic weighted average shares of common stock include any outstanding (i) Series B warrants issued in November 2022, (ii) pre-funded warrants issued in June 2024, May 2025 and January 2026 and (iii) vested RSUs in which their release were deferred.

Since we reported a net loss for the three and six months ended June 30, 2026 and 2025, our potentially dilutive securities are deemed to be anti-dilutive, accordingly, there was no effect of dilutive securities. Therefore, our basic and diluted loss per share of common stock and our basic and diluted weighted average shares of common stock are the same for the three and six months ended June 30, 2026 and 2025.

The following table sets forth the potentially dilutive securities that were not included in the calculation of diluted earnings per share of common stock for three and six months ended June 30, 2026 and 2025:

As of June 30,

  ​ ​ ​

2026

2025

Stock options

420

420

RSUs

222,612

21,951

Warrants

8,943,612

706,477